About us
Mathematical modelling has transformed our understanding of the dynamics and control of infectious diseases, through concepts such as the reproduction number, herd immunity, and theory of epidemics.
In our group, we use infectious disease models to inform the design, implementation, and effectiveness of population health interventions, particularly vaccines and immunotherapeutics.
In pursuing these outcomes, we draw on a diverse range of mathematical and statistical techniques, including differential equations, computational methods, stochastic processes, and optimisation theory.
We are motivated by seeing insights from our work become tangible policy and practice outcomes. This is reflected by our contributions to national and global vaccine policy, and membership of peak advisory bodies such as ATAGI and the WHO IVIR-AC.
We welcome expressions of interest from prospective research students or postdoctoral staff.
Our people
Our work
Our projects
School collaborators
Collaborate with us
Are you a student or post-doctoral聽fellow looking to colloborate? We have projects available related to topics on COVID-19, RSV, and influenza, including:
- Vaccination for longer-term COVID-19 mitigation in Australia
- COVID-19-induced interruptions to transmission of respiratory pathogens
- Approaches to modelling SARS-COV-2 immunity
- Capturing maternally-derived immunity models for RSV
- Revised models of interventions to inform future pandemic planning
- Integration of novel surveillance data in models of respiratory pathogen control聽
Please contact james.wood@unsw.edu.au or alexandra.hogan@unsw.edu.au for more information.
Our publications
-
2023
Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE,听2023,听'Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa',听Influenza and other Respiratory Viruses,听17,听
Conway E; Walker CR; Baker C; Lydeamore MJ; Ryan GE; Campbell T; Miller JC; Rebuli N; Yeung M; Kabashima G; Geard N; Wood J; McCaw JM; McVernon J; Golding N; Price DJ; Shearer FM,听2023,听'COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting',听Proceedings of the Royal Society B: Biological Sciences,听290,听pp. 20231437,听
Hogan AB; Doohan P; Wu SL; Mesa DO; Toor J; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC,听2023,听'Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach',听Nature Communications,听14,听
Hogan AB; Wu SL; Toor J; Mesa DO; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC,听2023,听'Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study',听PLoS Medicine,听20,听
Imai N; Rawson T; Knock ES; Sonabend R; Elmaci Y; Perez-Guzman PN; Whittles LK; Kanapram DT; Gaythorpe KAM; Hinsley W; Djaafara BA; Wang H; Fraser K; FitzJohn RG; Hogan AB; Doohan P; Ghani AC; Ferguson NM; Baguelin M; Cori A,听2023,听'Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study',听The Lancet Public Health,听8,听pp. e174 - e183,听
Jayasundara D; Randall D; Sheridan S; Sheppeard V; Liu B; Richmond PC; Blyth CC; Wood JG; Moore HC; McIntyre PB; Gidding HF,听2023,听'Estimating the excess burden of pertussis disease in Australia within the first year of life, that might have been prevented through timely vaccination',听International journal of epidemiology,听52,听pp. 250 - 259,听
McHugh L; Dyda A; Guglielmino C; Buckley C; Lau CL; Jennison AV; Regan DG; Wood J; Whiley D; Trembizki E,听2023,听'The changing epidemiology of Neisseria gonorrhoeae genogroups and antimicrobial resistance in Queensland, Australia, 2010-15: A case series analysis of unique Neisseria gonorrhoeae isolates',听Sexual Health,听20,听pp. 296 - 302,听
Padeniya TN; Hui BB; Wood JG; Seib KL; Regan DG,听2023,听'The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting',听Vaccine,听41,听pp. 5553 - 5561,听
Tobin RJ; Wood JG; Jayasundara D; Sara G; Walker CR; Martin GE; McCaw JM; Shearer FM; Price DJ,听2023,听'Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia',听BMC Infectious Diseases,听23,听
Wood JG; Heywood AE; Dennington PM; Lloyd AR; Ziegler JB,听2023,听'Trends in intravenous immunoglobulin use in New South Wales, Australia',听Internal Medicine Journal,听
-
2024
(Science Working Life)
2023
聽(The Conversation)
聽(The Conversation)
聽(The Conversation)